Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Apr 23.
Published in final edited form as: Chem Commun (Camb). 2024 Apr 23;60(34):4589–4592. doi: 10.1039/d4cc00465e

Copper(I)-free Syntheses of [11C/18F]Trifluoromethyl Ketones from Alkyl- or Aryl Esters and [11C/18F]Fluoroform

Susovan Jana 1, Sanjay Telu 1,*, Jimmy E Jakobsson 1, Bo Yeun Yang 1, Victor W Pike 1,*
PMCID: PMC11047764  NIHMSID: NIHMS1983842  PMID: 38577766

Abstract

Herein, we report a copper(I)-free method for labeling the trifluoroacetyl group with positron-emitting carbon-11 (t1/2 = 20.4 min) or fluorine-18 (t1/2 = 109.8 min) as part of our exploration of radiolabeled fluoroforms to access new radiolabeled chemotypes of interest for tracer development. Treatment of alkyl esters and aryl esters, containing electron-donating or electron-withdrawing groups, with [11C/18F]fluoroform in the presence of strong base, gave [11C/18F]trifluoromethyl ketones as novel radiolabeling synthons in moderate to high yields within 15 minutes.

Graphical Abstract

graphic file with name nihms-1983842-f0001.jpg


The positron emitters, carbon-11 (t1/2 = 20.4 min) and fluorine-18 (t1/2 = 109.8 min), are highly important for labeling tracers for positron emission tomography (PET) – a biomedical imaging modality that is now indispensable for research,12 drug development,34 and medical diagnosis.5 Carbon-11 and fluorine-18 play complementary roles in PET because of the differences in their half-lives and radiochemical utility. Versatile radiochemistry has been developed for installing carbon-11 into tracers, predominantly at methyl and carbonyl positions,68 whereas chemistry for creating carbon fluorine-18 bonds is now very advanced.89 Nonetheless, there remains a great need and interest in expanding the chemotypes that can be labeled with these positron-emitters.

In drug candidates, a trifluoromethyl group (CF3) may favorably enhance bioavailability, metabolic stability, and binding selectivity, and may also allow fine-tuning of the lipophilicity for pharmacokinetic benefit.1011 The trifluoroacetyl group (COCF3) is found in many drug molecules (Figure 1)1214 and therefore the introduction of a trifluoroacetyl group has attracted considerable synthetic effort.15 In addition, trifluoromethyl ketones (TFMKs) are very useful synthons for the syntheses of important classes of compounds, such as trifluoromethyl alcohols and amines,1518 lactones,1921 and heterocycles.22

Figure 1:

Figure 1:

Examples of bioactive small molecules containing a trifluoroacetyl moiety.

[11C]Fluoroform is readily synthesized23 and converted into reactive [11C]CF3Cu(I), which has been utilized to produce [11C]trifluoromethylarenes in high molar activities from aryl iodides, boronic acids, diazonium salts,2425 or diaryliodonium salts.26 [11C]Trifluoromethylstyrenes have also been produced from arylvinyliodonium salts.27

Several methods have been developed to produce [18F]fluoroform.28 We have developed a convenient method for gas phase [18F]fluoroform synthesis in good yield and molar activity.29 As in the case of the copper(I) derivative of [11C]fluoroform, the copper(I) derivative of [18F]fluoroform, [18F]CF3Cu(I) has been used widely for labeling trifluoromethylarenes.28 In this study, we aimed to explore the reactivity of no-carrier-added [11C/18F]fluoroform in the absence of copper(I) and to expand the chemical space for producing new PET tracers.

Carboxylic acids and their derivatives have been converted readily into trifluoromethyl ketones15 by using various “CF3” sources such as CF3CO2Na,30 AgCF3,31 TMSCF3,3235 or fluoroform3637 (Scheme 1, Eq. 1). Despite these advances, only a few methods are reported for producing [11C/18F]trifluoromethyl ketones. Prakash et al.38 utilized difluoroenol silyl ethers and carrier-added [18F]fluorine (18F-F) in acetonitrile at −30 °C to afford 18F-labeled aryl trifluoromethyl ketones in low yields and very low molar activities (15–20 MBq/μmol) (Scheme 1, Eq. 2). Gomez et al.39 radiofluorinated 2-bromo-2,2-difluoromethyl amides with [18F]n-Bu4NF in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in DMF at 100 °C for 10 minutes to produce [18F]trifluoroacetamides, but obtained very low yields and low molar activities (8.2 GBq/μmol). More recently, Meyer et al.14 reported that radiofluorination of 2-halo-2,2-difluoromethyl ketones with [18F]n-Bu4NF in the presence of 1,5,7-triazabicyclo-[4.4.0]dec-5-ene (TBD) in DMF at 75 °C for 10 minutes gave the [18F]aryltrifluoromethyl ketones in moderate to high yields but again with very low molar activities (0.41–1.27 GBq/μmol) (Scheme 1, Eq. 2). Here, we demonstrate the syntheses of both aryl and alkyl 11C/18F-trifluoromethyl ketones by using no-carrier-added [11C/18F]fluoroform and a suitable base under mild conditions (Scheme 1, Eq. 3).

Scheme 1:

Scheme 1:

Methods for synthesizing aryl and alkyl trifluoromethyl ketones.

To address our aims, we started by testing the 11C-trifluoromethylation of methyl benzoate (1a, 50 μmol) with [11C]fluoroform in the presence of KOtBu (15 μmol) in DMF at RT for 10 minutes, followed by quench of the reaction with 12M HCl (0.1 mL) and heating at 60 °C for 5 minutes. To our delight, this reaction furnished [11C]2,2,2-trifluoro-1-phenylethanone ([11C]2a) in good yield (65%) (Table 1, entry 1). In an attempt to increase the yield, other bases such as P1-t-Bu, BEMP, and KHMDS (15 μmol each) were investigated. All these bases were ineffective in producing [11C]2a (Table 1, entries 2–4). Increasing the amount of KOtBu to 45 μmol however increased the yield of [11C]2a substantially to 83% (Table 1, entry 5). Yields were found to be rather insensitive to lower HCl concentrations down to 0.5M (Table 1, entries 6–8). P1-t-Bu and BEMP (45 μmol) still failed to afford any [11C]2a (Table 1, entries 9 and 10), whereas increasing the amount of KHMDS to 45 μmol gave [11C]2a in 79% yield (Table 1, entry 11) under identical reaction conditions. Moreover, increasing KOtBu to 60 μmol substantially decreased the yield of [11C]2a to 42% (Table 1, entry 12). but the same amounts of P1-t-Bu and BEMP (60 μmol) produced no product (Table 1, entries 13 and 14). Highest yield (87%) of [11C]2a was obtained with 60 μmol KHMDS (Table 1, entry 15) and somewhat lower yield (77%) was obtained with 75 μmol KHMDS (Table 1, entry 16). Not surprisingly, 25 μmol of KHMDS failed to afford any [11C]2a (Table 1, entry 17). Because 45 μmol of KOtBu gave the best yield of [11C]2a and the yield was only a little less than that with 60 μmol KHMDS, we decided to study substrate scope with KOtBu (45 μmol) as base in DMF at RT for 10 minutes followed by quenching with 4M HCl (0.1 mL) at 60 °C for 5 minutes. We tested several methyl esters for 11C-trifluoromethylation under these conditions (Table 2).

Table 1:

Optimization for the formation of [11C]2,2,2-trifluoro-1-phenylethanone ([11C]2a).a,b,c

graphic file with name nihms-1983842-t0002.jpg
Entry Base Amount (μmol) HCl (M) Yield (%)
1 KOtBu 15 12 65 ± 10
2 P1-t-Bu 15 12 0
3 BEMP 15 12 0
4 KHMDS 15 12 0
5 KOtBu 45 12 83 ± 3
6 KOtBu 45 4 84 ± 5
7 KOtBu 45 2 81 ± 2
8 KOtBu 45 0.5 75 ± 8
9 P1-t-Bu 45 4 0
10 BEMP 45 4 0
11 KHMDS 45 4 79 ± 2
12 KOtBu 60 4 42 ± 5
13 P1-t-Bu 60 4 0
14 BEMP 60 4 0
15 KHMDS 60 4 87 ± 3
16 KHMDS 75 4 77 ± 9
17 KHMDS 25 4 0
a

Reaction conditions: i) 1a (50 μmol), base, DMF (450–500 μL). [11C]Fluoroform was added in DMF (100–150 μL), giving a reaction volume of ~ 600 μL. ii) HCl (0.5‒12M, 100 μL), 60 °C, 5 min.

b

Each decay-corrected yield is from [11C]fluoroform and determined with radio-HPLC. Yield was also measured at least once from the radioactivity of isolated [11C]2,2,2-trifluoro-1-phenylethanone ([11C]2a) as a percentage of the radioactivity collected from the HPLC column; these yields are very similar to the HPLC yields. (Note that 11C-labeled byproducts from the synthesis of [11C]fluoroform were excluded for the calculation of yields).

c

Reactions were performed in triplicate (n = 3) and the radio-HPLC yield is shown as mean ± SD for n = 3. [P1-t-Bu = tert-Butylimino-tris(dimethylamino)phosphorane; BEMP = 2-tert-Butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine; KHMDS = Potassium hexamethyldisilazide].

Table 2.

Substate scope for aryl- or alkyl-[11C]trifluoromethyl ketones ([11C]2a2o) synthesis.a,b,c

graphic file with name nihms-1983842-t0003.jpg
a

Reaction conditions: i) 1a1o (50 μmol), KOtBu (45 μmol), DMF (450–500 μL), [11C]Fluoroform was added in DMF solution (100–150 μL) to give a reaction volume of ~ 600 μL. ii) 4M HCl (100 μL), 60 °C, 5 min.

b

Radio-HPLC yields (%) are shown in blue;

c

Reactions were performed in triplicate (n = 3);

d

KHMDS (45 μmol) was used because 45 μmol KOtBu gave much lower yield;

e

Isolated yield (n = 2) in green.

The methyl benzoates, 1a‒1j, bearing either an electron-withdrawing or electron-donating group afforded the desired aryl products, [11C]2a‒2j, in mostly moderate to excellent yields (15‒95%), except for methyl 4-nitro benzoate (1i) which gave no yield. We indicate that the iodo- and bromo-substituted compounds, [11C]2e, [11C]2h and [11C]2j, might be used in a metal-catalyzed C‒C coupling or C‒H activation reactions. We measured the molar activity (Am) of [11C]2e to exemplify the no-carrier-added nature of this radiochemical procedure. [11C]2e was isolated in about 80% decay-corrected yield with 97.5% radiochemical purity and a high molar activity (Am = 56 ± 6 GBq/μmol; n = 2) at the end of synthesis (60 min from the production of [11C]methane using a 15 μA x 15 min cyclotron irradiation). Such a high molar activity is fully consitent with a NCA procedure. The ortho-methyl substituted ester, 1b, gave only 15% yield of [11C]2b, but the ortho-fluoro benzoate, 1c, produced [11C]2c in excellent yield (82%). These reactions, when performed in the presence of 45 μmol KOtBu, gave much lower yields of [11C]2b and [11C]2c, respectively. However, much higher yields of [11C]2b and [11C]2c were obtained by using 45 μmol KHMDS. The 11C-trifluoromethylation of α,β-unsaturated esters, 1k‒1l, was also successful in producing the 11C-trifluoromethylketones [11C]2k and [11C]2l, giving 77% and 23% yields, respectively. A very good yield of 69% was obtained for 11C-labeled 3-(2,2,2-trifluoroacetyl)pyridine [11C]2m by 11C-trifluoromethylation of methyl nicotinate (1m). Finally, to extend the scope of 11C-trifluoromethylketones formation, we also tested alkyl esters, 1n‒1o, under optimal 11C-trifluoromethylation conditions (Table 1, entry 5). These reactions produced alkyl [11C]trifluoromethylketones [11C]2n and [11C]2o in moderate to excellent yields of 22% and 82%, respectively.

We then focused on the synthesis of [11C]2,2,2-trifluoro-1-(4-nitrophenyl)ethenone ([11C]2i) because the earlier optimal reaction conditions (Table 1, entry 5) failed to render any product. Previous studies suggest that 2,2,2-trifluoro-1-(4-nitrophenyl)ethenone (2i) is moisture sensitive and therefore, exists as 2,2,2-trifluoro-1-(4-nitrophenyl)ethane-1,1-diol (3i).31 Nevertheless, to achieve a successful reaction with methyl 4-nitrobenzoate (1i), we further tuned the reaction conditions (Table 3). 11C-Trifluoromethylation of the methyl ester (1i) was still inefficient with 15 μmol, 45 μmol, and 125 μmol KOtBu (Table 3, entries 1‒3) or with 25 μmol KHMDS (Table 3, entry 4). We sought to utilize a Weinreb’s amide (1p) to produce [11C]3i because Rudzinski et al. reported that such amides are effective precursors for synthesizing trifluoromethyl ketones.33 Amide 1p failed to provide [11C]3i in the presence of 25 μmol KHMDS (Table 3, entry 5). However, we were delighted to find that 1p underwent successful 11C-trifluoromethylation in the presence of 45 μmol KHMDS as base to afford [11C]3i in good yield (60%) (Table 3, entry 6). The yield of [11C]3i was improved substantially to 92% by using 60 μmol KHMDS as base (Table 3, entry 7).

Table 3:

Optimization for the formation of 2,2,2-trifluoro-1-(4-nitrophenyl)ethane-1,1-diol ([11C]3i).a,b

graphic file with name nihms-1983842-t0004.jpg
Entry R Base μmol Yield (%)
1 OMe (1i) KOtBu 15 0
2 OMe (1i) KOtBu 45 0
3 OMe (1i) KOtBu 125 0
4 OMe (1i) KHMDS 25 0
5 N(OMe)Me (1p) KHMDS 25 0
6 N(OMe)Me (1p) KHMDS 45 60 ± 6
7 N(OMe)Me (1p) KHMDS 60 92 ± 2
a

Reaction conditions: i) 1i or 1p (50 μmol), base, DMF (450–500 μL). [11C]Fluoroform was added in DMF solution (~ 100–150 μL) to give a reaction volume of ~ 600 μL. ii) 4M HCl; 60 °C, 5 min.

b

Decay-corrected yields were measured from radio-HPLC chromatograms as mean ± SD for n = 3.

We emphasize that this radiosynthetic method can be adapted easily for use with [18F]fluoroform when there is a need for radiotracers with longer physical half-life. We verified this potential by achieving a 79% yield of [18F]2a from 1a, utilizing [18F]fluoroform under the optimal reaction conditions described in Table 1, entry 6. 18F-Trifluoromethylation of 1d was also successful in giving a high yield (94%) for [18F]2d. However, a much lower yield (32%) was obtained for [18F]2j from 1j under optimal conditions. We speculate that an unknown impurity in the [18F]fluoroform (which is used in crude form) led to the lower yield, in this case (Table 4).

Table 4.

Reaction scope leading to the formation of aryl- [18F]trifluoromethyl ketones ([18F]2)a,b,c

graphic file with name nihms-1983842-t0005.jpg
a

Reaction conditions: i) 1a, 1d or 1j (50 μmol), KOtBu (45 μmol), DMF (450–500 μL); [18F]Fluoroform was added in DMF solution (~ 100–150 μL) to give a reaction volume of ~ 600 μL. ii) 4M HCl (100 μL), 60 °C, 5 min;

b

Radio-HPLC yields (%) are shown in blue.

c

Reactions were performed in triplicate (n = 3).

In summary, we have developed a new method for the copper (I)-free syntheses of no-carrier-added 11C- and 18F-labeled trifluoromethyl ketones as new radiolabeled chemotypes from the reactions between aryl- and alkyl esters with [11C/18F]fluoroform in presence of a suitable base under mild conditions. The no-carrier-added radiolabeled products were obtained in moderate to excellent radiochemical yields (15‒95%) within 15 minutes. This methodology can be expanded into a modular method for synthesizing a diverse range of 11C- and 18F-labeled tracers.

Supplementary Material

SI

Acknowledgments

We acknowledge the Intramural Research Program of the National Institutes of Health (NIMH; ZIA-MH002793) for financial support and thank the NIH Clinical Center (Chief Dr. P. Herscovitch) for radioisotope production.

Footnotes

Electronic Supplementary Information (ESI) available: See DOI: 10.1039/x0xx00000x

Conflicts of interest

There are no conflicts to declare.

Notes and references

  • 1.Phelps ME, Proc. Natl. Acad. Sci. U.S.A, 2000, 97, 9226–9233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Willmann JK, van Bruggen N, Dinkelborg LM and Gambhir SS, Nat. Rev. Drug. Discov, 2008, 7, 591–607. [DOI] [PubMed] [Google Scholar]
  • 3.Donnelly DJ, in Handbook of Radiopharmaceuticals, Eds. Scott PJH and Kilbourn MR, John Wiley & Sons Ltd., Hoboken, NJ, 2nd Edn., 2021, ch. 22, pp. 703–725. [Google Scholar]
  • 4.Suridjan I, Comley RA and Rabiner EA, Brain Imaging Behav, 2019, 13, 354–365. [DOI] [PubMed] [Google Scholar]
  • 5.Unterrainer M, Eze C, Ilhan H, Marschner S, Roengvoraphoj O, Schmidt-Hegemann NS, Walter F, Kunz WG, Rosenschold PMA, Jeraj R, Albert NL, Grosu AL, Niyazi M, Bartenstein P and Belka C, Radiat. Oncol, 2020, 15, 88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Taddei C and Pike VW, EJNMMI Radiopharm. Chem, 2019, 4, 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wuest F, Berndt M and Kniess T, in PET Chemistry - The Driving Force in Molecular Imaging, Eds. Schubiger PA, Lehmann L and Friebe M, Springer, 2007, ch. 7, pp. 183–213. [Google Scholar]
  • 8.Lu S, Siméon FG, Telu S, Cai LS and Pike VW, in Advances in Heterocyclic Chemistry, Eds. Scriven EFV and Ramsden CA, Academic Press, Elsevier, 2020, vol. 132, ch. 4, pp. 241–384. [Google Scholar]
  • 9.Siméon FG, Telu S, Cai LS, Lu S and Pike VW, in The Chemistry of Organofluorine Compounds, PATAI’S Chemistry of Functional Groups, Eds. Marek I, Gouverneur V and Gandelman M, John Wiley & Sons Ltd, Chichester, UK, in press, DOI: 10.1002/9780470682531.pat1035. [DOI] [Google Scholar]
  • 10.Purser S, Moore PR, Swallow S and Gouverneur V, Chem. Soc. Rev, 2008, 37, 320–330. [DOI] [PubMed] [Google Scholar]
  • 11.Gillis EP, Eastman KJ, Hill MD, Donnelly DJ and Meanwell NA, J. Med. Chem, 2015, 58, 8315–8359. [DOI] [PubMed] [Google Scholar]
  • 12.Veale CA, Damewood J, R. J, Steelman GB, Bryant C, Gomes B and Williams J, J. Med. Chem, 1995, 38, 86–97. [DOI] [PubMed] [Google Scholar]
  • 13.Nikolaou A, Kokotou MG, Vasilakaki S and Kokotos G, Biochim. Biophys. Acta. Mol. Cell Biol. Lipids, 2019, 1864, 941–956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Meyer DN, Cortes Gonzalez MA, Jiang X, Johansson-Holm L, Pourghasemi Lati M, Elgland M, Nordeman P, Antoni G and Szabo KJ, Chem. Commun, 2021, 57, 8476–8479. [DOI] [PubMed] [Google Scholar]
  • 15.Zhang J, Ke Q, Chen J, He P and Yan G, Chin. J. Org. Chem, 2019, 39, 74–83. [Google Scholar]
  • 16.Xu J, Liu Z-J, Yang X-J, Wang L-M, Chen G-L and Liu J-T, Tetrahedron, 2010, 66, 8933–8937. [Google Scholar]
  • 17.Onyeagusi CI and Malcolmson SJ, ACS Catal, 2020, 10, 12507–12536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Park D, Jette CI, Kim J, Jung WO, Lee Y, Park J, Kang S, Han MS, Stoltz BM and Hong S, Angew. Chem. Int. Ed, 2020, 59, 775–779. [DOI] [PubMed] [Google Scholar]
  • 19.Wang X-N, Shao P-L, Lv H and Ye S, Org. Lett, 2009, 11, 4029–4031. [DOI] [PubMed] [Google Scholar]
  • 20.Xiao H, Duan HY, Ye J, Yao RS, Ma J, Yuan ZZ and Zhao G, Org. Lett, 2014, 16, 5462–5465. [DOI] [PubMed] [Google Scholar]
  • 21.Crotti S, Di Iorio N, Mazzanti A, Righi P and Bencivenni G, J. Org. Chem, 2018, 83, 12440–12448. [DOI] [PubMed] [Google Scholar]
  • 22.Hsieh M-T, Kuo S-C and Lin H-C, Adv. Synth. Catal, 2015, 357, 683–689. [Google Scholar]
  • 23.Haskali MB and Pike VW, Chem. Eur. J, 2017, 23, 8156–8160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Telu S, Siméon FG, Lu S and Pike VW, in PATAI’S Chemistry of Functional Groups, Eds. Rappoport Z, Leibman JF and Marek I, John Wiley & Sons Ltd., Hoboken, NJ, 2018, DOI: 10.1002/9780470682531.pat0955, pp. 1–59. [DOI] [Google Scholar]
  • 25.Luo Z, Cahard D and Tsui GC, J. Fluorine Chem, 2023, 266, 110092. [Google Scholar]
  • 26.Telu S, Jana S, Haskali MB, Yang BY, Jakobsson JE, Zhao Q, Ramos-Torres KM, Brugarolas P and Pike VW, Chem. Eur. J, 2023, 29, e202204004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jana S, Telu S, Yang BY, Haskali MB, Jakobsson JE and Pike VW, Org. Lett, 2020, 22, 4574–4578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Francis F and Wuest F, Molecules, 2021, 26, 6478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yang BY, Telu S, Haskali MB, Morse CL and Pike VW, Sci. Rep, 2019, 9, 14835–14844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chang Y and Cai C, J. Fluorine Chem, 2005, 126, 937–940. [Google Scholar]
  • 31.Kremlev MM, Mushta AI, Tyrra W, Naumann D, Fischer HTM and Yagupolskii YL, J. Fluorine Chem, 2007, 128, 1385–1389. [Google Scholar]
  • 32.Wiedemann J, Heiner T, Mloston G, Prakash GKS and Olah GA, Angew. Chem. Int. Ed, 1998, 37, 820–821. [DOI] [PubMed] [Google Scholar]
  • 33.Rudzinski DM, Kelly CB and Leadbeater NE, Chem. Commun, 2012, 48, 9610–9612. [DOI] [PubMed] [Google Scholar]
  • 34.Liu X, Liu L, Huang T, Zhang J, Tang Z, Li C and Chen T, Org. Lett, 2021, 23, 4930–4934. [DOI] [PubMed] [Google Scholar]
  • 35.Said MS, Khonde NS, Kumar P and Gajbhiye JM, Org. Lett, 2023, 25, 1094–1098. [DOI] [PubMed] [Google Scholar]
  • 36.Zhang Y, Fujiu M, Serizawa H and Mikami K, J. Fluorine Chem, 2013, 156, 367–371. [Google Scholar]
  • 37.Fujihira Y, Liang Y, Ono M, Hirano K, Kagawa T and Shibata N, Beilstein J. Org. Chem, 2021, 17, 431–438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Prakash GKS, Alauddin MM, Hu J, Conti PS and Olah GA, J. Label. Compd. Radiopharm, 2003, 46, 1087–1092. [Google Scholar]
  • 39.Gómez AB, Cortés Gonzaláz MA, Lübcke M, Johansson MJ, Halldin C, Szabó KJ and Schou M, Chem. Commun, 2016, 52, 13963–13966. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES